Ambient Clinical Analytics, the remote patient monitoring firm which became independent from Mayo Clinic in 2013, has elevated $1.5 million in a round led by Noaber Ventures. Noaber Ventures is the extended investment arm of Noaber Foundation and the company’s first European investor. The already existing investors such as Mayo Clinic, Bluestem Capital and Social Capital have also contributed to the round.

CEO Allen Berning said, “The company is making great progress, and interest is rising nationwide from large system hospitals; We feel we are well positioned to make Ambient Clinical Analytics the market leader when it comes to real-time analytics-based clinical decision support solutions.”

Ambient Clinical Analytics offers an FDA-cleared monitoring platform named AWARE.

AWARE stands for Ambient Warning and Response Evaluation and is a monitoring interface for EHR data which organizes a patient’s medical information in three ways: by organ, as a chronological timeline or as a customized checklist which shows the relevant next steps to that case.

Sepsis DART was offered to identify and provide digital guidance for treating sepsis. Mayo Clinic offered a patient tracking tool named YES Board, which allows the staff in emergency departments to monitor the status of all patients from the screens in every department.

Matthijs Blokhuis, the managing director of Noaber Ventures, said “We are seeing many investment opportunities within digital health, however, only a few have the ability to create meaningful results for patients by increasing patient outcome and systematically reducing costs; we believe Ambient has a proper validated product and the right kind of people onboard to actually create such impact.”